Theravance Biopharma financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

테라반스 바이오파머NASDAQ:TBPH · Nasdaq

$17.03+0.00%

2026-09-25 close

Theravance Biopharma's published financial data is dated 2026-10-04. 2024 revenue was $64M. 2024 operating profit was −$47M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy